RxDB
ICD-9-CM Codes ICD-9-PCS Codes

0014 - Injection or infusion of oxazolidinone class of antibiotics

Overview

GEM Conversion to ICD-10 PCS

Fs: 10000 – Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach
Fs: 10000 – Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Muscle, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Peripheral Vein, Open Approach
Fs: 10000 – Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Central Vein, Open Approach
Fs: 10000 – Introduction of Oxazolidinones into Central Vein, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Peripheral Artery, Open Approach
Fs: 10000 – Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Central Artery, Open Approach
Fs: 10000 – Introduction of Oxazolidinones into Central Artery, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Nose, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Nose, External Approach
Fs: 10000 – Introduction of Oxazolidinones into Ear, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Ear, External Approach
Fs: 10000 – Introduction of Oxazolidinones into Eye, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Eye, External Approach
Fs: 10000 – Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Mouth and Pharynx, External Approach
Fs: 10000 – Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Upper GI, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Lower GI, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening
Fs: 10000 – Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic
Fs: 10000 – Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach
Fs: 10000 – Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Epidural Space, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Joints, Open Approach
Fs: 10000 – Introduction of Oxazolidinones into Joints, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Bones, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Lymphatics, Percutaneous Approach
Fs: 10000 – Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach

Sibling Codes

Implantation of chemotherapeutic agent
Infusion of drotrecogin alfa (activated)
Administration of inhaled nitric oxide
Injection or infusion of nesiritide
Injection or infusion of oxazolidinone class of antibiotics
High-dose infusion interleukin-2 [IL-2]
Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance
Infusion of vasopressor agent
Infusion of immunosuppressive antibody therapy
Disruption of blood brain barrier via infusion [BBBD]